About Deverra Therapeutics
Deverra Therapeutics is a private company based in Seattle, Washington, incorporated in 2019 in Delaware. It has reported $2,463,889 raised in two offerings on Form D since August 2020. Its chief executive is Michael Yurkowsky.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2023 | Sep 18, 2023 | $2,388,889fully sold | 1 | $2.3M | Debt, OptionsRule 506(b), 3(c), 3(c)(1) | Form D ↗ |
| Aug 20, 2020 | Aug 27, 2020 | $75,000of $3.5M target | 2 | $37,500 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $2,463,889 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Deverra Therapeutics's Form D filed Sep 18, 2023.
MY
Michael Yurkowsky
Chief Executive Officer
CD
Colleen Delaney
Executive officer